In acute uncomplicated sinusitis, which statement is true?

In acute uncomplicated sinusitis, which statement is true?

• A. Decongestants are recommended as adjunctive therapy
• B. Minimum of 7 days after resolution of symptoms
• C. 5-day course of high-dose amoxicillin is as efficacious as longer courses of standard-dose antibiotic treatment
• D. Clindamycin is the drug of choice in children with a PCN allergy

Answer: (B)

In acute bacterial sinusitis in children, the duration of antibiotic therapy matters to ensure the infection is fully eradicated while minimizing unnecessary exposure. A commonly accepted practice is to treat for a total course of about seven to ten days, with many clinicians aiming for at least seven days of therapy to reduce the risk of relapse and to give the antibiotic enough time to work. The statement that the minimum duration is seven days after symptoms have resolved fits with this approach: continuing treatment for a full week (or more) after the patient has improved helps ensure complete resolution of the infection and lowers the chance of recurrence. The other points don’t align with standard recommendations: decongestants are not routinely advised as adjunctive therapy in uncomplicated cases due to limited proven benefit and potential adverse effects; for penicillin-allergic children, clindamycin is not the preferred first-line agent because it doesn’t cover all common sinusitis pathogens as reliably and has broader resistance concerns; and while shorter, high-dose antibiotic courses have been studied, guidelines generally do not endorse a universal five-day course as equivalent to longer, standard-dose regimens for all pediatric cases.

In acute bacterial sinusitis in children, the duration of antibiotic therapy matters to ensure the infection is fully eradicated while minimizing unnecessary exposure. A commonly accepted practice is to treat for a total course of about seven to ten days, with many clinicians aiming for at least seven days of therapy to reduce the risk of relapse and to give the antibiotic enough time to work.

The statement that the minimum duration is seven days after symptoms have resolved fits with this approach: continuing treatment for a full week (or more) after the patient has improved helps ensure complete resolution of the infection and lowers the chance of recurrence. The other points don’t align with standard recommendations: decongestants are not routinely advised as adjunctive therapy in uncomplicated cases due to limited proven benefit and potential adverse effects; for penicillin-allergic children, clindamycin is not the preferred first-line agent because it doesn’t cover all common sinusitis pathogens as reliably and has broader resistance concerns; and while shorter, high-dose antibiotic courses have been studied, guidelines generally do not endorse a universal five-day course as equivalent to longer, standard-dose regimens for all pediatric cases.